17.36
Finanzdaten der Relay Therapeutics Inc-Aktie (RLAY)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
88.33%
0.35
|
3.00 | 7.00 | - | 0.677 |
| Operating Expenses |
11.75%
91.17
|
81.59 | 67.63 | 80.39 | 77.52 |
| Operating Income/Loss |
15.57%
-90.82
|
-78.59 | -60.63 | -80.39 | -76.85 |
| Net Income/Loss |
14.21%
-83.71
|
-73.29 | -54.89 | -74.15 | -70.38 |
| Basic Average Shares |
12.79%
202.85
|
179.85 | 0.6127 | 172.39 | 171.26 |
| Basic Earnings Per Share |
0.00%
-0.41
|
-0.41 | -0.31 | -0.43 | -0.41 |
| Diluted Earnings Per Share |
0.00%
-0.41
|
-0.41 | -0.31 | -0.43 | -0.41 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):